Zhao et al. uncovered a novel mechanism of DDB2 that could bind to the promoter region of NEDD4L to activate the TGF-β signaling pathway in ovarian cancer cells, finally improving the sensitivity of cells to TGF-β-induced growth inhibition [22]. The gene discussed is DDB2; the disease is ovarian cancer.